Invention Grant
US09029533B2 Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitors
有权
取代的炔基咪唑并[1,2-A]哒嗪作为激酶抑制剂
- Patent Title: Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitors
- Patent Title (中): 取代的炔基咪唑并[1,2-A]哒嗪作为激酶抑制剂
-
Application No.: US13801116Application Date: 2013-03-13
-
Publication No.: US09029533B2Publication Date: 2015-05-12
- Inventor: Dong Zou , Wei-Sheng Huang , R. Mathew Thomas , Jan Antoinette C. Romero , Jiwei Qi , Yihan Wang , Xiaotian Zhu , William C. Shakespeare , Rajeswari Sundaramoorthi , Chester A. Metcalf, III , David C. Dalgarno , Tomi K. Sawyer
- Applicant: ARIAD Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: ARIAD Pharmaceuticals, Inc.
- Current Assignee: ARIAD Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agent David L. Berstein; Gretchen S. Peterson
- Main IPC: C07D237/26
- IPC: C07D237/26 ; C07D487/04 ; C07D471/04 ; C07D473/34
![Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitors](/abs-image/US/2015/05/12/US09029533B2/abs.jpg.150x150.jpg)
Abstract:
This invention relates to compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use.
Public/Granted literature
- US20130231337A1 Bicyclic Heteroaryl Compounds Public/Granted day:2013-09-05
Information query